ISIN | LU0648597655 |
---|---|
Valor Number | 13354335 |
Bloomberg Global ID | BBG00228Q756 |
Fund Name | MFS Meridian Funds Blended Research European Equity A1 EUR |
Fund Provider |
MFS International Limited
London, United Kingdom Phone: +44 20 7429 7200 |
Fund Provider | MFS International Limited |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) |
Carnegie Fund Services S.A. Genève 11 Phone: +41 22 705 11 77 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The Fund’s objective is capital appreciation, measured in Euros. The Fund invests primarily (at least 70%) in European equity securities. Some of the countries in Europe, primarily those in Eastern Europe, are currently considered emerging market economies. The Fund may invest in companies it believes to have above average earnings growth potential compared to other companies (growth companies), in companies it believes are undervalued compared to their perceived worth (value companies), or in a combination of growth and value companies. The Fund generally focuses its investments in larger companies, but may invest in companies of any size. The Fund may invest a relatively large percentage of its assets in a small number of countries and/or a particular geographic region. |
Peculiarities |
Current Price * | 35.93 EUR | 02.06.2025 |
---|---|---|
Previous Price * | 35.73 EUR | 30.05.2025 |
52 Week High * | 35.93 EUR | 02.06.2025 |
52 Week Low * | 30.04 EUR | 05.08.2024 |
NAV * | 35.93 EUR | 02.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 177,193,981 | |
Unit/Share Assets *** | 3,229,636 | |
Trading Information SIX |
YTD Performance | +13.81% |
31.12.2024 - 02.06.2025
31.12.2024 02.06.2025 |
---|---|---|
YTD Performance (in CHF) | +13.06% |
31.12.2024 - 02.06.2025
31.12.2024 02.06.2025 |
1 month | +4.60% |
02.05.2025 - 02.06.2025
02.05.2025 02.06.2025 |
3 months | +2.45% |
03.03.2025 - 02.06.2025
03.03.2025 02.06.2025 |
6 months | +12.81% |
02.12.2024 - 02.06.2025
02.12.2024 02.06.2025 |
1 year | +13.17% |
03.06.2024 - 02.06.2025
03.06.2024 02.06.2025 |
2 years | +29.20% |
02.06.2023 - 02.06.2025
02.06.2023 02.06.2025 |
3 years | +34.42% |
02.06.2022 - 02.06.2025
02.06.2022 02.06.2025 |
5 years | +77.87% |
02.06.2020 - 02.06.2025
02.06.2020 02.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 3.24% | |
---|---|---|
Roche Holding AG | 3.09% | |
ASML Holding NV | 3.03% | |
Iberdrola SA | 2.26% | |
Novo Nordisk AS Class B | 2.20% | |
Banco Santander SA | 2.18% | |
Sanofi SA | 2.13% | |
Rolls-Royce Holdings PLC | 2.11% | |
Schneider Electric SE | 2.10% | |
Zurich Insurance Group AG | 1.99% | |
Last data update | 30.04.2025 |
TER *** | 1.60% |
---|---|
TER date *** | 31.01.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 1.60% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |